Results 101 to 110 of about 32,481 (179)

Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease Rebound. [PDF]

Vaccines (Basel)
Findlow J, Htar MTT, Villena R, Balmer P.   +3 more
europepmc   +1 more source

Incidence of infection associated with eculizumab: a meta-analysis of 9 randomized controlled trials. [PDF]

Front Pharmacol
Jiang A, Liu Y, Wei C, Xiao G.
europepmc   +1 more source

Isolated Neisseria meningitidis-associated endophthalmitis in an immunocompetent host: case report and literature review. [PDF]

Access Microbiol
Lo CK, Hughes L, Schonhofer C, Bowie WR, McCormick I, Kirker A.   +5 more
europepmc   +1 more source

Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections. [PDF]

Emerg Infect Dis
van Hal SJ, Le T, Jenkins F, Kundu RL, Limnios EA, McNamara LA, Sharma S, Kersh EN, Lahra MM.   +8 more
europepmc   +1 more source

Genetic and Antigenic Diversity of <i>Neisseria meningitidis</i> Serogroup B Strains in Vietnam. [PDF]

Pathogens
Long TP, Cuong VV, Anh BTL, Van Toan T, Loan VT, Hung PV, Anh LTL, Tan NN, Mo LT, Van Khanh L, Van Tong H.   +10 more
europepmc   +1 more source

Protection against <i>N. gonorrhoeae</i> induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses. [PDF]

Front Immunol
Zhu W, Waltmann A, Little MB, Connolly KL, Matthias KA, Thomas KS, Gray MC, Sikora AE, Criss AK, Bash MC, Macintyre AN, Jerse AE, Duncan JA.   +12 more
europepmc   +1 more source

Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children. [PDF]

Infect Dis Ther
Martinón-Torres F, Simko R, Ebert R, Rämet M, Zocchetti C, Syrkina O, Bchir S, Bertrand-Gerentes I.   +7 more
europepmc   +1 more source

Coverage disparities and delayed immunization: Assessing 12-month vaccination completion in Canadian children using data from a digital immunization platform. [PDF]

Hum Vaccin Immunother
Serhan M, Nilormi A, Ntacyabukura B, Atkinson K, Ducharme R, Hawken S, Ramsay T, Ang J, Wilson K.   +8 more
europepmc   +1 more source

Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study. [PDF]

Clin Infect Dis
Nolan T, Bhusal C, Hoberman A, Llapur CJ, Voloshyna O, Fink E, Gentile A, Wallace G, Richmond PC, Domachowske JB, Mzolo T, Lattanzi M, Toneatto D, BOOST Study Group .   +13 more
europepmc   +1 more source